QX031N
Respiratory Diseases
PreclinicalActive
Key Facts
About Qyuns Therapeutics
Publicly traded biotech developing antibody therapies for autoimmune and allergic diseases with a pipeline targeting IL-4Rα, IL-17A, IL-23, and TSLP pathways.
View full company profileTherapeutic Areas
Other Respiratory Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Inhalation APIs | ChemWerth | Approved |
| Synthetic VLP Vaccines | nCage Therapeutics | Pre-clinical |
| Respiratory Portfolio | Phargentis | Not Disclosed |
| Not specifically disclosed on public website | Taisho Pharmaceutical | Various |